APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Better serving global partners and advancing healthcare innovation
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Subscribe To Our Newsletter & Stay Updated
